HSIC · Henry Schein Inc
Price
Snapshot
50 fields · last close| Market Cap | $10.13B |
| P/E | 25.03 |
| Float | 97.22M |
| Beta | 0.87 |
| Volatility | 21.7% |
| Exchange | NASDAQ |
| Sector | Health Care |
| Cap tier | Large cap |
| Macro sensitivity | Moderate |
| Clavix score | 84 |
| Price | 90.31 |
| Change | −0.61% |
| Prev Close | 90.86 |
| Open | 90.68 |
| Day Low | 89.56 |
| Day High | 91.69 |
| Avg Vol | 1 |
| Avg $ Vol | $73.80M |
| 52W High | 92.18 |
| 52W Low | 61.95 |
| 52W Pos | 93.8% |
| From High | −2.03% |
| From Low | +45.78% |
| Max DD 1Y | −17.23% |
| Spread | 0.10% |
| Liquidity | Normal |
| SMA 20 | +0.91% |
| SMA 50 | +3.43% |
| SMA 200 | +14.33% |
| RSI (14) | 61.5 |
| Vol 30D | 16.5% |
| Vol 90D | 23.1% |
| 1Y Range | 62–92 |
| Daily bars | 506 |
| Perf Week | +0.64% |
| Perf Month | +1.42% |
| Perf Quarter | +19.08% |
| Perf Half Y | +13.33% |
| Perf Year | +35.35% |
| Perf YTD | +17.56% |
| Prev Day | −0.61% |
| Clavix | A- |
| Debt / Eq | 0.96 |
| Curr Ratio | 1.38 |
| Int Cover | 5.4× |
| FCF Margin | 4.9% |
| Rev Growth | +6.7% |
| Profit | Profitable |
| Leverage | Moderate |
| Sector rank | 2 / 47 |
What HSIC does
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide.
It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments.
The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services.
It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services.
The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers.
The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics.
Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
Clavix risk grade
regraded every trading dayHSIC grades A-, 84 of 100. Steadiest on Price Stability (69), most exposed on News Sentiment (68, steady). 4 of the 4 weighted dimensions sit above the Health Care median. Ranks 2 of 47 in Health Care by Clavix score.
How rough the ride is
| HSIC | Health Care median | |
|---|---|---|
| Betavs the overall market · lower is steadier | 0.87 | 0.81 |
| Volatilityannualized | 21.7% | 20.4% |
| Max drawdown, past yearworst peak-to-trough fall | −17.2% | — |
| Typical daily movemedian absolute daily change | 0.91% | — |
| Days beyond ±3%of the last 252 sessions | 166% | — |
How its days are spread
Daily returns over the last 252 sessions in 1% bins. Moves beyond ±6% land in the end bins.
52-week range
The bar runs from the lowest to the highest close of the last 252 sessions; the marker is the latest close.
Drawdown from the 1-year peak
Percent below the running high over the last 12 months. Zero is a fresh high.
Market sensitivity
| HSIC | Health Care median | |
|---|---|---|
| Beta to the markethow much it swings with the S&P 500 · lower is safer | 0.87 | 0.81 |
| Macro sensitivityrate, dollar and credit exposure bucket | Moderate | Moderate55% of 47 |
Where it sits on the macro scale
Low means rates, the dollar and credit spreads barely move it. Very High means they drive a large share of its swings. The counts are how many Health Care names sit in each bucket.
Where it ranks in its sector
Rank by Clavix score within the sector. Right is the top of the sector.
Price performance
| HSIC | |
|---|---|
| 1 week | +0.6% |
| 1 month | +1.4% |
| Year to date | +17.6% |
| 1 year | +35.3% |
Context for the rank, not itself a risk measure.
Recent coverage, scored
| HSIC | |
|---|---|
| Articles scoredthe most recent scored coverage, up to 30 | 30since 23 Jun |
| Average score0 most bearish, 100 most bullish | 62 |
| Bullish · bearisharticles above 60 · below 40 | 22 · 6 |
| Directionarticles whose tone is improving vs worsening | 22 ↑ 6 ↓ |
Where the article scores land
Each bar is a 10-point band of article scores. Below 40 reads bearish, above 60 bullish.
Balance sheet, against the sector
The shaded band is the middle half of the 47 Health Care names Clavix covers; the tick is the sector median.
Growth
| HSIC | |
|---|---|
| Revenue growthyear over year | +6.7% |
Financial Health is shown but does not count toward the grade. Why
0–100, higher is safer. The tick on each bar is the Health Care median. Click a dimension for the evidence behind it. Financial Health is shown but does not count toward the grade.
Against Health Care
47 companies| Metric | HSIC | Sector spread | Median |
|---|---|---|---|
| Beta | 0.87 | 0.81 | |
| Volatility | 21.7% | 20.4% | |
| P/E | 25.03 | 26.14 | |
| Debt / equity | 0.96 | 0.71 | |
| Current ratio | 1.38 | 1.58 | |
| FCF margin | 4.9% | 8.6% | |
| Interest coverage | 5.4× | 6.3× |
Recent news
most recent scored articles · the chip is the article’s score · click to openZacks Research lowered its earnings per share estimates for Henry Schein's (HSIC) third quarter of 2026 in a note issued to clients on Monday, August 24th. The article body is cut off and does not include the new estimate figures.
BTIG Research raised its price target on Henry Schein from $100 to $110 and gave the stock a 'buy' rating on Wednesday. No reason for the change was given.
Henry Schein raised its 2026 outlook after stronger Q2 sales and margins, though the company still needs to deliver on cost savings in the second half to keep earnings momentum going.
Henry Schein raised its 2026 outlook after reporting stronger sales and profit margins in Q2, though executing planned cost savings in the second half of the year is key to sustaining earnings momentum.
Wall Street Zen raised its rating on Henry Schein (HSIC) from "hold" to "buy" on Monday. No price target or reasoning was provided in the note.
Nearest peers by size
Health Care| Ticker | Company | Grade | Mkt cap | P/E | Beta | |
|---|---|---|---|---|---|---|
| UHS | Universal Health Services Inc | A- | $9.97B | 6.59 | 1.13 | Compare |
| PODD | Insulet Corp | C | $10.44B | 27.37 | 1.08 | Compare |
| GMED | Globus Medical Inc | B | $10.49B | 20.23 | 0.99 | Compare |
| MOH | Molina Healthcare Inc | B | $10.59B | 22.36 | 0.73 | Compare |
| GKOS | Glaukos Corp | B- | $10.64B | — | 0.73 | Compare |
| ALGN | Align Technology Inc | B- | $11.36B | 27.26 | 1.73 | Compare |
| DVA | DaVita Inc | B | $11.59B | 13.70 | 0.89 | Compare |
| BTSG | Brightspring Health Services Inc | B- | $12.15B | 32.56 | 1.86 | Compare |
You just read one holding. Clavix reads the whole portfolio.
Every position you own, graded on the same five dimensions, with an alert when a grade moves. Three months free on iPhone.